missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CD179a Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA563199
This item is not returnable.
View return policy
Description
Immunogen sequence: QPVLHQPPAM SSALGTTIRL TCTLRNDHDI GVYSVYWYQQ RPGHPPRFLL RYFSQSDKSQ GPQVPPRFSG SKDVARNRGY LSISELQPED EAMYYCAMGA RSSEKEERER EWEEEMEPT Highest antigen sequence identity to the following orthologs: Mouse - 76%, Rat - 75%.
The protein encoded by this gene belongs to the immunoglobulin superfamily and is expressed selectively at the early stages of B cell development, namely, in proB and early preB cells. This gene encodes the iota polypeptide chain that is associated with the Ig-mu chain to form a molecular complex which is expressed on the surface of pre-B cells. The complex is thought to regulate Ig gene rearrangements in the early steps of B-cell differentiation.
Specifications
| CD179a | |
| Polyclonal | |
| Unconjugated | |
| VPREB1 | |
| CD179 antigen-like family member A; CD179a; IGI; IGLL1; IGVPB; Immunoglobulin iota chain; Immunoglobulin lambda Vpreb1 chain; immunoglobulin lambda-1 light chain; immunoglobulin lambda-like polypeptide 5; LOC100735142; pre-B lymphocyte 1; pre-B lymphocyte gene 1; Protein VPreB1; surrogate light chain; v(pre)B protein; VPREB; VpreB protein; Vpreb1; Vpreb-1; V-set pre-B cell surrogate light chain 1 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 7441 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin) | |
| 0.2 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| P12018 | |
| VPREB1 | |
| Recombinant protein corresponding to Human CD179a. Recombinant protein control fragment (Product #RP-91363). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction